Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype (NADMet)

NCT02950441 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT02950441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02950441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype (NADMet)
Lead sponsor
University of Birmingham
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2016
Completion date
September 30, 2019
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging